Treatment of Dysfunctional Uterine Bleeding in Reproductive-Age Women
First-line medical treatment for dysfunctional uterine bleeding (ovulatory dysfunction without structural pathology) should be either combined hormonal contraception or progestin-only contraception, with the levonorgestrel-releasing intrauterine system being the most effective option. 1
Medical Management Algorithm
First-Line Hormonal Options
Combined hormonal contraception (oral contraceptive pills, patch, or ring) effectively reduces menstrual blood loss and regulates cycles in women with ovulatory dysfunction 1. This works by stabilizing the endometrium and preventing irregular proliferation 2.
Progestin-only methods are equally effective first-line options 1:
- Levonorgestrel-releasing intrauterine system (LNG-IUS) is the most effective medical therapy, achieving satisfaction rates comparable to hysterectomy while avoiding surgical risks 2, 3
- Continuous oral progestins can be used when intrauterine devices are not desired 2
- Depot medroxyprogesterone acetate injections provide another progestin-only alternative 2
Non-Hormonal Medical Options
Tranexamic acid is the most effective non-hormonal medical therapy for reducing menstrual blood loss, working through antifibrinolytic mechanisms 2, 3. This is particularly valuable for women who cannot or prefer not to use hormonal methods 2.
Nonsteroidal anti-inflammatory drugs (NSAIDs) reduce menstrual bleeding by 20-50% and can be combined with hormonal methods or tranexamic acid for additive benefit 2, 3.
Acute Heavy Bleeding Management
For acute abnormal uterine bleeding requiring immediate intervention 2, 4:
- Intravenous estrogen for hemodynamically unstable patients
- High-dose combined oral contraceptive regimen (multidose protocol: one pill every 6-8 hours until bleeding stops, then taper)
- Multidose progestin-only regimen as alternative
- Tranexamic acid for rapid hemostasis 2
Surgical Intervention Criteria
Endometrial ablation or hysterectomy should be considered when 1:
- Medical treatment fails to control bleeding adequately
- Medical treatment is contraindicated (e.g., history of thromboembolism, breast cancer)
- Patient cannot tolerate medical therapy due to side effects
- Concomitant significant intracavitary lesions are present (polyps, submucosal fibroids) 1
Endometrial ablation (first or second-generation techniques) provides high patient satisfaction with lower morbidity than hysterectomy, though long-term data on second-generation techniques remain limited 5, 3. The LNG-IUS achieves comparable quality of life outcomes to hysterectomy without surgical risks 3.
Hysterectomy remains definitive treatment with the highest satisfaction rates but carries higher complication rates and should be reserved for failed medical/ablative therapy or patient preference after counseling 3.
Special Populations
Women with bleeding disorders can use all hormonal methods plus tranexamic acid effectively 2.
Women on anticoagulation should preferentially use progestin-only methods or GnRH agonists to minimize bleeding risk 2.
Perimenopausal women may benefit from GnRH agonists as bridge therapy before surgical intervention if fibroids are present 2.
Critical Pitfalls to Avoid
Before initiating treatment, you must exclude pregnancy, structural pathology (via transvaginal ultrasound), and endometrial malignancy/hyperplasia 1, 6. Endometrial biopsy is indicated in women over 45 years or those with risk factors for endometrial cancer (obesity, PCOS, diabetes, unopposed estrogen exposure) 6, 7.
Medical management is inappropriate when significant structural lesions (large fibroids, polyps) are identified on imaging, as these require surgical management 1, 6.